- Investing Ideas
- /
- U.S. Top High Growth Tech & AI Stocks - Spotless Financials
U.S. Top High Growth Tech & AI Stocks - Spotless Financials
Results
71
Companies within the technology and artificial intelligence (AI) sector, that exhibit significant growth potential, providing opportunities to capitalize on the rapid advancement and innovation within the industry.
71 companies
Palantir Technologies
Market Cap: US$422.6b
Palantir Technologies Inc. builds and deploys software platforms for the intelligence community to assist in counterterrorism investigations and operations in the United States, the United Kingdom, and internationally.
PLTR
US$178.15
7D
1.5%
1Y
314.6%
OS Therapies
Market Cap: US$58.5m
A clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States.
OSTX
US$1.85
7D
-7.0%
1Y
-38.7%
Workday
Market Cap: US$60.8b
Provides enterprise cloud applications in the United States and internationally.
WDAY
US$234.25
7D
0.5%
1Y
-4.2%
Gorilla Technology Group
Market Cap: US$480.8m
Provides solutions in security, network, business intelligence, and Internet of Things (IoT) technology in Taiwan and the United Kingdom.
GRRR
US$16.95
7D
-6.3%
1Y
299.8%
Circle Internet Group
Market Cap: US$29.7b
Operates as a platform, network, and market infrastructure for stablecoin and blockchain applications.
CRCL
US$126.49
7D
-4.9%
1Y
n/a
Zscaler
Market Cap: US$47.4b
Operates as a cloud security company worldwide.
ZS
US$300.25
7D
-3.1%
1Y
58.0%
Vanda Pharmaceuticals
Market Cap: US$311.4m
A biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs worldwide.
VNDA
US$5.27
7D
-0.8%
1Y
7.3%
ADMA Biologics
Market Cap: US$3.5b
A biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally.
ADMA
US$14.36
7D
-1.2%
1Y
-9.0%
Aldeyra Therapeutics
Market Cap: US$323.6m
A biotechnology company, discovers and develops therapies designed to treat immune-mediated and metabolic diseases.
ALDX
US$5.26
7D
-2.4%
1Y
-7.7%
Exelixis
Market Cap: US$10.6b
An oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States.
EXEL
US$39.25
7D
2.9%
1Y
35.8%
RenovoRx
Market Cap: US$42.9m
A clinical-stage biopharmaceutical company, engages in the developing of targeted combination therapies to enhance therapeutic outcomes for cancer patients undergoing treatment.
RNXT
US$1.12
7D
0.9%
1Y
12.0%
HubSpot
Market Cap: US$22.8b
Provides a cloud-based customer relationship management (CRM) platform for businesses in the Americas, Europe, and the Asia Pacific.
HUBS
US$436.82
7D
-0.6%
1Y
-18.7%
Atlassian
Market Cap: US$39.5b
Provides a collaboration software that enables organizations to connect all teams through a system of work that unlocks productivity at scale worldwide.
TEAM
US$151.95
7D
5.1%
1Y
-20.7%
Kiniksa Pharmaceuticals International
Market Cap: US$2.9b
A biopharmaceutical company, developing and commercializing novel therapies for diseases with unmet need and focuses on cardiovascular indications worldwide.
KNSA
US$38.64
7D
2.0%
1Y
47.1%
Cellebrite DI
Market Cap: US$4.4b
Develops solutions for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific.
CLBT
US$18.18
7D
-4.8%
1Y
0.2%
Zeta Global Holdings
Market Cap: US$4.3b
Operates an omnichannel data-driven cloud platform that provides enterprises with consumer intelligence and marketing automation software in the United States and internationally.
ZETA
US$17.82
7D
-3.2%
1Y
-36.1%
Market Cap: US$37.2b
Operates a digital community in the United States and internationally.
RDDT
US$194.95
7D
-1.8%
1Y
141.0%
Commvault Systems
Market Cap: US$7.6b
Provides a cyber resilience platform for protecting and recovering data and cloud-native applications in the Americas and internationally.
CVLT
US$171.90
7D
1.0%
1Y
22.0%
Krystal Biotech
Market Cap: US$5.5b
A commercial-stage biotechnology company, discovers, develops, manufactures, and commercializes genetic medicines to treat diseases with high unmet medical needs in the United States.
KRYS
US$190.23
7D
4.8%
1Y
6.2%
Anavex Life Sciences
Market Cap: US$773.9m
Operates as a biopharmaceutical company.
AVXL
US$8.98
7D
-3.1%
1Y
58.9%
BioRestorative Therapies
Market Cap: US$13.7m
Develops therapeutic products and medical therapies using cell and tissue protocols primarily involving adult stem cells.
BRTX
US$1.59
7D
-2.2%
1Y
-4.8%
Cheetah Mobile
Market Cap: US$223.7m
Provides internet services, artificial intelligence (AI), and other services in the People’s Republic of China, Hong Kong, Japan, and internationally.
CMCM
US$7.39
7D
1.8%
1Y
88.0%
Protalix BioTherapeutics
Market Cap: US$191.4m
A biopharmaceutical company, engages in the development, production, and commercialization of recombinant therapeutic proteins based on the ProCellEx plant cell-based protein expression system.
PLX
US$1.86
7D
-21.2%
1Y
70.6%
Creative Medical Technology Holdings
Market Cap: US$10.4m
A commercial-stage biotechnology company, focuses on novel biological therapeutics in the fields of immunotherapy, endocrinology, urology, neurology, and orthopedics in the United States.
CELZ
US$3.59
7D
7.8%
1Y
-18.6%
Gyre Therapeutics
Market Cap: US$793.8m
A pharmaceutical company, engages in the development and commercialization of small-molecule, anti-inflammatory, and anti-fibrotic drugs targeting organ fibrosis.
GYRE
US$8.30
7D
4.3%
1Y
-41.0%
Trade Desk
Market Cap: US$24.4b
Operates as a technology company in the United States and internationally.
TTD
US$49.98
7D
-4.5%
1Y
-57.9%
Evaxion
Market Cap: US$60.6m
A clinical-stage biotech company, develops artificial intelligence-powered immunology vaccines.
EVAX
US$6.79
7D
15.1%
1Y
-48.6%
Glimpse Group
Market Cap: US$31.8m
An immersive technology company provides enterprise focused virtual reality (VR), augmented reality (AR), and spatial computing software and services in the United States.
VRAR
US$1.50
7D
2.7%
1Y
134.4%
MNTN
Market Cap: US$1.1b
Operates a technology platform that brings performance marketing to Connected TV.
MNTN
US$15.03
7D
-6.4%
1Y
n/a
Aprea Therapeutics
Market Cap: US$9.0m
A clinical-stage biopharmaceutical company, focuses on developing and commercializing novel synthetic lethality-based cancer therapeutics that targets DNA damage response pathways.
APRE
US$1.57
7D
10.6%
1Y
-64.3%
Pure Storage
Market Cap: US$30.2b
Provides data storage and management technologies, products, and services in the United States and internationally.
PSTG
US$91.85
7D
2.8%
1Y
60.9%
Applied Optoelectronics
Market Cap: US$1.9b
Designs, manufactures, and sells fiber-optic networking products in the United States, Taiwan, and China.
AAOI
US$31.92
7D
17.6%
1Y
71.9%
Protagonist Therapeutics
Market Cap: US$4.7b
A biopharmaceutical company, develops peptide therapeutics for hematology and blood disorders, and inflammatory and immunomodulatory diseases.
PTGX
US$77.50
7D
-10.9%
1Y
65.0%
GeoVax Labs
Market Cap: US$16.7m
A clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms in the United States.
GOVX
US$0.55
7D
-0.5%
1Y
-73.9%
Arcturus Therapeutics Holdings
Market Cap: US$590.1m
Engages in the development of infectious disease vaccines and other products within liver and respiratory rare diseases.
ARCT
US$20.66
7D
9.0%
1Y
-2.3%
VTEX
Market Cap: US$766.1m
Provides software-as-a-service digital commerce platform for enterprise brands and retailers.
VTEX
US$4.19
7D
0.7%
1Y
-39.3%